OMB control number

Infant Formula Recall Regulations

OMB 0910-0188 ยท HHS/FDA.

OMB 0910-0188

This collection request supports agency regulations requiring information from manufacturers of infant formula that allows FDA to conduct effective recalls of infant formula should it become necessary.

The latest form for Infant Formula Recall Regulations expires 2023-12-31 and is listed under ICR 202010-0910-012.

All Historical Document Collections

Historical document collections
ReferenceFilingReceivedConcludedAction
202010-0910-012 Extension without change of a currently approved collection 2020-11-27 Approved without change
201710-0910-010 Extension without change of a currently approved collection 2017-11-09 Approved without change
201410-0910-010 Extension without change of a currently approved collection 2014-10-27 Approved without change
201108-0910-013 Extension without change of a currently approved collection 2011-08-30 Approved without change
200807-0910-005 Extension without change of a currently approved collection 2008-07-17 Approved without change
200505-0910-007 Extension without change of a currently approved collection 2005-05-27 Approved without change
200206-0910-001 Extension without change of a currently approved collection 2002-06-07 Approved without change
199905-0910-010 Extension without change of a currently approved collection 1999-05-21 Approved without change
199611-0910-002 Reinstatement without change of a previously approved collection 1996-11-20 Approved without change
199509-0910-017 No material or nonsubstantive change to a currently approved collection 1995-09-30 Approved without change
199212-0910-004 Revision of a currently approved collection 1992-12-28 Approved without change
198910-0910-003 Reinstatement with change of a previously approved collection 1989-10-16 Approved without change
198710-0910-002 Reinstatement with change of a previously approved collection 1987-10-01 Approved without change
198402-0910-003 New collection (Request for a new OMB Control Number) 1984-02-27 Approved without change

OMB Details

Reporting: Requirements for Written Recall Strategy Furnished to Appropriate FDA District Office By Recalling Firm

Federal Enterprise Architecture: Health - Consumer Health and Safety